{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:27:12Z","timestamp":1759937232553},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12882-017-0757-5","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T11:28:19Z","timestamp":1513078099000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Intractable ascites associated with mycophenolate in a simultaneous kidney-pancreas transplant patient: a case report"],"prefix":"10.1186","volume":"18","author":[{"given":"Nina T.","family":"Weber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Sigaroudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Boss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuno","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Farese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Weiler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas F.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,12]]},"reference":[{"issue":"Suppl 1","key":"757_CR1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1191\/0961203305LU2109OA","volume":"14","author":"AC Allison","year":"2005","unstructured":"Allison AC. Mechanisms of action of mycophenolate mofetil. Lupus. 2005;14(Suppl 1):2\u20138.","journal-title":"Lupus"},{"issue":"2\u20133","key":"757_CR2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","volume":"47","author":"AC Allison","year":"2000","unstructured":"Allison AC. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology. 2000;47(2\u20133):85\u2013118.","journal-title":"Immunopharmacology"},{"issue":"1","key":"757_CR3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1681\/ASN.V131277","volume":"13","author":"JH Helderman","year":"2002","unstructured":"Helderman JH. Gastrointestinal complications of transplant immunosuppression. J Am Soc Nephrol. 2002;13(1):277\u201387.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"757_CR4","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00204-014-1247-1","volume":"88","author":"CE Staatz","year":"2014","unstructured":"Staatz CE. Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update. Arch Toxicol. 2014;88(7):1351\u201389.","journal-title":"Arch Toxicol"},{"issue":"2","key":"757_CR5","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1053\/j.ajkd.2007.07.036","volume":"51","author":"JP Lafrance","year":"2008","unstructured":"Lafrance JP. Successful treatment of encapsulating peritoneal sclerosis with immunosuppressive therapy. Am J Kidney Dis. 2008;51(2):e7\u201310.","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"757_CR6","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1007\/s10620-006-9727-7","volume":"52","author":"M Markov","year":"2007","unstructured":"Markov M. Ascites and kidney transplantation: case report and critical appraisal of the literature. Dig Dis Sci. 2007;52(12):3383\u20138.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"757_CR7","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1053\/j.ajkd.2005.06.019","volume":"46","author":"KL Lentine","year":"2005","unstructured":"Lentine KL. De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications. Am J Kidney Dis. 2005;46(4):720\u201333.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"757_CR8","doi-asserted-by":"crossref","first-page":"394","DOI":"10.6002\/ect.2011.0180","volume":"10","author":"GJ Jaffers","year":"2012","unstructured":"Jaffers GJ. Surgical correction of nephrogenic ascites in a renal transplant recipient. Exp Clin Transplant. 2012;10(4):394\u20137.","journal-title":"Exp Clin Transplant"},{"issue":"9237","key":"757_CR9","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"IR Edwards","year":"2000","unstructured":"Edwards IR. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255\u20139.","journal-title":"Lancet"},{"issue":"8","key":"757_CR10","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00007890-199810270-00027","volume":"66","author":"D Ducloux","year":"1998","unstructured":"Ducloux D. Mycophenolate mofetil-induced villous atrophy. Transplantation. 1998;66(8):1115\u20136.","journal-title":"Transplantation"},{"issue":"5","key":"757_CR11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.TP.0000053753.43268.F0","volume":"75","author":"BD Maes","year":"2003","unstructured":"Maes BD. Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea. Transplantation. 2003;75(5):665\u201372.","journal-title":"Transplantation"},{"issue":"7","key":"757_CR12","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1016\/j.transproceed.2011.04.016","volume":"43","author":"H Malekinejad","year":"2011","unstructured":"Malekinejad H. Nitric oxide and acute phase proteins are involved in pathogenesis of mycophenolate mofetil-induced gastrointestinal disorders in rats. Transplant Proc. 2011;43(7):2741\u20136.","journal-title":"Transplant Proc"},{"issue":"7","key":"757_CR13","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/01902148.2011.570416","volume":"37","author":"DE Monguillhott","year":"2011","unstructured":"Monguillhott DE. Evidence of an anti-inflammatory effect of mycophenolate mofetil in a murine model of pleurisy. Exp Lung Res. 2011;37(7):399\u2013407.","journal-title":"Exp Lung Res"},{"issue":"1","key":"757_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5414\/CN107140","volume":"77","author":"E Hur","year":"2012","unstructured":"Hur E. The effects of mycophenolate mofetil on encapsulated peritoneal sclerosis model in rats. Clin Nephrol. 2012;77(1):1\u20137.","journal-title":"Clin Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-017-0757-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T07:41:36Z","timestamp":1660117296000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-017-0757-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["757"],"URL":"https:\/\/doi.org\/10.1186\/s12882-017-0757-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"360"}}